Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity. 2002

Binghe Wang, and Claudio Feliciani, and Brandon G Howell, and Irwin Freed, and Qinchao Cai, and Hideaki Watanabe, and Daniel N Sauder
Department of Dermatology, Johns Hopkins University, Baltimore, MD 21287, USA.

The epidermal Langerhans cells (LC), a member of the dendritic cell family, and the LC-derived cytokine IL-12 play a pivotal role in the initiation of contact hypersensitivity (CHS), a Th1 immune response in the skin. Because IL-18, another LC-derived cytokine, shares functional and biological properties with IL-12, we examined a potential role for IL-18 in CHS initiation. Our studies demonstrated that during the induction phase of murine CHS, IL-18 mRNA was significantly up-regulated in the skin-draining lymph nodes (LN). Migratory hapten-modified LC in LN expressed high levels of IL-18 mRNA and secreted functional IL-18 protein. LN cells produced significant amounts of IFN-gamma following in vitro IL-12 stimulation, which could be partially blocked by anti-IL-18 Ab, suggesting a synergistic role for endogenous IL-18 in IFN-gamma production by LN cells. Because mature IL-18 requires cleavage of immature precursors by caspase-1, we further examined IL-12-induced IFN-gamma production in caspase-1(-/-) LN cells. An impaired IFN-gamma production was seen in caspase-1(-/-) LN cells, which could be restored by addition of exogenous IL-18, supporting a role for caspase-1-cleaved, mature IL-18 in IFN-gamma production. Finally, in vivo studies showed that CHS responses were significantly inhibited in mice treated with neutralizing IL-18 Ab as well as in caspase-1(-/-) mice deficient in mature IL-18, indicating functional relevance for IL-18 in CHS. Taken together, our studies demonstrate that LC-derived IL-18 significantly contributes to CHS initiation.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007801 Langerhans Cells Recirculating, dendritic, antigen-presenting cells containing characteristic racket-shaped granules (Birbeck granules). They are found principally in the stratum spinosum of the EPIDERMIS and are rich in Class II MAJOR HISTOCOMPATIBILITY COMPLEX molecules. Langerhans cells were the first dendritic cell to be described and have been a model of study for other dendritic cells (DCs), especially other migrating DCs such as dermal DCs and INTERSTITIAL DENDRITIC CELLS. Langerhans Cell,Dendritic Cells, Dermal,Dendritic Cells, Epidermal,Dendritic Cells, Skin,Dermal Dendritic Cells,Epidermal Dendritic Cells,Skin Dendritic Cells,Cell, Dermal Dendritic,Cell, Epidermal Dendritic,Cell, Langerhans,Cell, Skin Dendritic,Cells, Dermal Dendritic,Cells, Epidermal Dendritic,Cells, Langerhans,Cells, Skin Dendritic,Dendritic Cell, Dermal,Dendritic Cell, Epidermal,Dendritic Cell, Skin,Dermal Dendritic Cell,Epidermal Dendritic Cell,Skin Dendritic Cell
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010081 Oxazolone Immunologic adjuvant and sensitizing agent. 2-Phenyl-4-(ethoxymethylene)oxazol-5-one,4-Ethoxymethylene-2-phenyloxazolone,4 Ethoxymethylene 2 phenyloxazolone
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell

Related Publications

Binghe Wang, and Claudio Feliciani, and Brandon G Howell, and Irwin Freed, and Qinchao Cai, and Hideaki Watanabe, and Daniel N Sauder
October 2009, Journal of immunology (Baltimore, Md. : 1950),
Binghe Wang, and Claudio Feliciani, and Brandon G Howell, and Irwin Freed, and Qinchao Cai, and Hideaki Watanabe, and Daniel N Sauder
February 2008, Journal of leukocyte biology,
Binghe Wang, and Claudio Feliciani, and Brandon G Howell, and Irwin Freed, and Qinchao Cai, and Hideaki Watanabe, and Daniel N Sauder
August 2003, Journal of immunology (Baltimore, Md. : 1950),
Binghe Wang, and Claudio Feliciani, and Brandon G Howell, and Irwin Freed, and Qinchao Cai, and Hideaki Watanabe, and Daniel N Sauder
July 1980, The Journal of investigative dermatology,
Binghe Wang, and Claudio Feliciani, and Brandon G Howell, and Irwin Freed, and Qinchao Cai, and Hideaki Watanabe, and Daniel N Sauder
December 2005, Immunity,
Binghe Wang, and Claudio Feliciani, and Brandon G Howell, and Irwin Freed, and Qinchao Cai, and Hideaki Watanabe, and Daniel N Sauder
January 2010, The Journal of investigative dermatology,
Binghe Wang, and Claudio Feliciani, and Brandon G Howell, and Irwin Freed, and Qinchao Cai, and Hideaki Watanabe, and Daniel N Sauder
January 2002, Annales de dermatologie et de venereologie,
Binghe Wang, and Claudio Feliciani, and Brandon G Howell, and Irwin Freed, and Qinchao Cai, and Hideaki Watanabe, and Daniel N Sauder
September 1981, The Journal of investigative dermatology,
Binghe Wang, and Claudio Feliciani, and Brandon G Howell, and Irwin Freed, and Qinchao Cai, and Hideaki Watanabe, and Daniel N Sauder
June 1986, The American Journal of dermatopathology,
Binghe Wang, and Claudio Feliciani, and Brandon G Howell, and Irwin Freed, and Qinchao Cai, and Hideaki Watanabe, and Daniel N Sauder
May 1988, The Journal of investigative dermatology,
Copied contents to your clipboard!